N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae
- PMID: 2657103
- PMCID: PMC250878
- DOI: 10.1128/JVI.63.7.3176-3179.1989
N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae
Abstract
A semisynthetic gene precisely encoding the 502 amino acids of the human immunodeficiency virus type 1 gag precursor (Pr53gag) was expressed in the yeast Saccharomyces cerevisiae. Amino acid sequence analysis of the recombinant Pr53gag showed that the amino terminus was fully blocked. Labeling of Pr53gag with [3H]myristic acid demonstrated that, as with Pr53gag isolated from virus-infected cells, the yeast-derived protein was demethionylated and N myristylated on glycine, the second amino acid residue.
Similar articles
-
Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast.Gene. 1992 Oct 1;119(2):273-7. doi: 10.1016/0378-1119(92)90282-t. Gene. 1992. PMID: 1398108
-
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5. doi: 10.1073/pnas.86.15.5781. Proc Natl Acad Sci U S A. 1989. PMID: 2788277 Free PMC article.
-
Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.J Virol. 1987 Apr;61(4):1045-53. doi: 10.1128/JVI.61.4.1045-1053.1987. J Virol. 1987. PMID: 3493352 Free PMC article.
-
The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.J Virol. 1988 Nov;62(11):3993-4002. doi: 10.1128/JVI.62.11.3993-4002.1988. J Virol. 1988. PMID: 3262776 Free PMC article.
-
Processing of retroviral Gag polyproteins: an in vitro approach.Methods Enzymol. 1994;241:227-53. doi: 10.1016/0076-6879(94)41067-4. Methods Enzymol. 1994. PMID: 7854180 Review. No abstract available.
Cited by
-
Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2055-9. doi: 10.1073/pnas.88.6.2055. Proc Natl Acad Sci U S A. 1991. PMID: 2006142 Free PMC article.
-
ESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplasts.PLoS One. 2012;7(12):e52603. doi: 10.1371/journal.pone.0052603. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23285107 Free PMC article.
-
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.J Virol. 1992 Nov;66(11):6587-600. doi: 10.1128/JVI.66.11.6587-6600.1992. J Virol. 1992. PMID: 1404605 Free PMC article.
-
HIV-1 Gag release from yeast reveals ESCRT interaction with the Gag N-terminal protein region.J Biol Chem. 2020 Dec 25;295(52):17950-17972. doi: 10.1074/jbc.RA120.014710. Epub 2020 Sep 28. J Biol Chem. 2020. PMID: 32994219 Free PMC article.
-
Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice.Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3409-13. doi: 10.1073/pnas.89.8.3409. Proc Natl Acad Sci U S A. 1992. PMID: 1565633 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical